ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Astrazeneca 31

Astrazeneca 31 (50UC)

106.475
-0.325
( -0.30% )
Updated: 03:17:57

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 22.47B22.09B24.38B26.62B37.42B44.35B45.81B54.07B
Operating Income 2.09B1.4B1.59B4.08B-293M3.54B7.89B9.91B
Pre Tax Income 2.23B1.99B1.55B3.92B-265M2.5B6.9B8.69B
Net Income 3B2.16B1.34B3.2B112M3.29B5.96B7.04B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 2.371.7011.0172.4350.0722.1223.8420
EBIT 3.46B3.27B2.81B5.14B216M3.75B8.18B9.98B
EBITDA 5.11B5.15B5.35B7.23B6.24B9.02B13.28B16.6B

Your Recent History

Delayed Upgrade Clock